A groundbreaking new study has uncovered a direct link between specific gut bacteria and the development of Multiple Sclerosis (MS), fueling the growing understanding that autoimmune diseases may originate in the gut—not just in the genetics or environment alone. Published in PNAS, this research analyzed 81 pairs of identical twins where only one sibling had MS and found two bacteria, Eisenbergiella tayi and Lachnoclostridium, consistently associated with the disease.
Key points:
- Researchers transplanted gut microbes from MS-afflicted twins into mice, which then developed MS-like symptoms.
- These bacteria thrive in the small intestine—a hot spot for immune regulation—and may trick the immune system into attacking nerve cells.
- Women showed higher susceptibility, mirroring MS’s disproportionate impact on females.
- The findings suggest dietary interventions, such as boosting fiber intake, could starve harmful bacteria while supporting beneficial microbes.
The gut-brain connection: How bacteria may drive autoimmunity
For years, scientists have suspected that MS—a debilitating autoimmune condition where the immune system erodes the protective myelin sheath around nerves—has strong ties to gut health. But this study moves beyond correlation to causation, showing that specific bacteria can directly provoke the disease. The researchers used fecal transplants from twins with MS into germ-free mice genetically prone to neurological inflammation. Within weeks, these mice developed paralysis, while those receiving bacteria from healthy twins remained symptom-free.
Drilling down further, the study pinpointed the small intestine—a region packed with immune cells—as the battleground where these bacteria manipulate immunity. Eisenbergiella tayi and Lachnoclostridium ferment fiber and produce short-chain fatty acids (SCFAs), which should be anti-inflammatory. But in MS, something goes awry: their metabolic activity might trigger immune dysfunction instead.
Eisenbergiella tayi:
A less-studied bacterium from the Firmicutes phylum, this strain is associated with MS in twin studies. It thrives in the small intestine, where it ferments dietary fibre into short-chain fatty acids (e.g., acetate, propionate). While SCFAs typically foster regulatory T cells (Tregs) to curb inflammation, in MS, E. tayi’s metabolites may instead promote Th17 cells—pro-inflammatory agents implicated in autoimmunity. Research suggests E. tayi might degrade mucin, compromising gut barrier integrity and allowing bacterial lipopolysaccharides (LPS) to leak into circulation, priming systemic inflammation.
Lachnoclostridium:
A genus within the Lachnospiraceae family, known for producing butyrate. Paradoxically, certain strains (e.g., L. bolteae) are linked to MS, possibly due to strain-specific effects or context-dependent interactions. In MS, Lachnoclostridium may shift from producing anti-inflammatory butyrate to pro-inflammatory succinate under low-fiber conditions. Some species metabolize tryptophan into indole derivatives, which can cross the blood-brain barrier and modulate neuroinflammation via aryl hydrocarbon receptor (AhR) signaling—a pathway dysregulated in MS.
Glyphosate, antibiotics, and modern diets are disrupting our gut balance
While genetics and viruses like Epstein-Barr can predispose someone to MS, the explosion of autoimmune diseases in industrialized nations suggests environmental toxins and processed diets play a major role. Glyphosate, the active ingredient in Roundup, has been shown to decimate gut bacteria, particularly those that digest fiber—ironically, the same beneficial strains (Lachnospiraceae) that were linked to MS in this study.
The modern Western diet—low in fiber, high in emulsifiers, and laden with pesticides—may be starving our good bacteria while feeding harmful ones. Could restoring balance through fiber-rich foods (think legumes, whole grains, and prunes) help suppress MS-triggering microbes?
This groundbreaking study not only solidifies the gut’s role in MS but also opens doors to microbiome-targeted therapies. The causal link—demonstrated via fecal transplants in mice—suggests that autoimmune triggers are modifiable, offering hope for environmental interventions like precision probiotics or phage therapy to selectively eradicate harmful strains. Meanwhile, dietary strategies (e.g., high-fiber, polyphenol-rich diets) may starve pro-inflammatory bacteria while nurturing Lactobacillus and Bifidobacterium, which counter Th17 dominance.
Critically, the study highlights sex-specific susceptibility, with female mice mirroring the 3:1 female-to-male MS prevalence in humans—possibly tied to estrogen’s modulation of gut permeability. Further, it challenges the hygiene hypothesis, proposing that industrialized lifestyles (e.g., glyphosate, ultra-processed foods) disrupt microbial harmony, creating a permissive environment for autoimmunity.
Dr. Wahls’ recovery—achieved via a paleo-inspired protocol rich in sulphur-containing vegetables and organ meats—exemplifies the potential of nutritional reprogramming to rebuild a resilient microbiome. Future research must explore bacterial consortia rather than single culprits, as ecological balance—not eradication—may hold the key. As we unravel the gut-brain-immune triad, one truth crystallizes: MS management may soon pivot from immunosuppression to microbial reconciliation.
Sources include:
Expose-News.com
PNAS.org
Enoch, Brighteon.ai
Read full article here